¼¼°èÀÇ ³»½Ã°æ Àçó¸® ½ÃÀå(2023-2030³â)
Global Endoscope Reprocessing Market - 2023-2030
»óǰÄÚµå : 1319133
¸®¼­Ä¡»ç : DataM Intelligence
¹ßÇàÀÏ : 2023³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 195 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,350 £Ü 5,990,000
PDF & Excel (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,850 £Ü 6,679,000
PDF & Excel (Multiple User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,850 £Ü 10,811,000
PDF & Excel (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

½ÃÀå °³¿ä

¼¼°è ³»½Ã°æ Àçó¸® ½ÃÀåÀº 2022³â 23¾ï ´Þ·¯, 2030³â¿¡´Â 45¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù(2023-2030³â 9.2%ÀÇ CAGR). ÀÇ·á¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ¿¬°á ±â´ÉÀÇ ÅëÇÕ, µ¥ÀÌÅÍ ÃßÀû, ¿ø°Ý ¸ð´ÏÅ͸µ ±â´É°ú °°Àº ±â¼úÀÇ ¹ßÀüÀº ³»½Ã°æ Àçó¸® ½ÃÀå µ¿Çâ¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.

³»½Ã°æ Àç󸮴 °¨¿° ¿¹¹æ ¹æ¹ý ¹× ÀÇ·á ¼ö¼ú Áß È¯ÀÚÀÇ ¾ÈÀüÀ» º¸ÀåÇÏ´Â µ¥ Áß¿äÇÕ´Ï´Ù. ³»½Ã°æ Àç󸮴 ȿ°úÀûÀÎ ¿À¿° Á¦°Å¸¦ º¸ÀåÇϰí ÀÇ·á °ü·Ã Áúº´ÀÇ À§ÇèÀ» ÁÙÀ̱â À§ÇØ Áß¿äÇÕ´Ï´Ù. ½ÃÀå¿¡´Â ÃÊÀ½ÆÄ ¼¼Ã´±â, »ì±Õ±â, ¼¼Ã´ ¼Òµ¶±â, °ÇÁ¶ ¹× º¸°ü ijºñ´Ö, ³»½Ã°æ ÃßÀû ½Ã½ºÅÛ ¹× ±âŸ ¼Ö·ç¼ÇÀÌ Æ÷ÇԵ˴ϴÙ.

¼¼°è ³»½Ã°æ Àçó¸® ½ÃÀåÀÇ ¹üÀ§´Â ³ôÀº ¼öÁØÀÇ ¼Òµ¶Á¦ ¹× Å×½ºÆ® ½ºÆ®¸³, ¼¼Á¦ ¹× ¹°Æ¼½´, ÀÚµ¿ ³»½Ã°æ Àçó¸®, ³»½Ã°æ °ÇÁ¶, º¸°ü ¹× ¿î¼Û ½Ã½ºÅÛÀ» Æ÷ÇÔÇÑ Á¦Ç° À¯Çüº°·Î ±¸¼ºµÇ¾î ÀÖÀ¸¸ç, ³»½Ã°æ Àçó¸® ½ÃÀå Á¡À¯À²ÀÇ »ç¿ë·üÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

³»½Ã°æ Àçó¸® ¼¼°è ½ÃÀåÀº ÀÇ·á °ü·Ã °¨¿°(HAI) À¯º´·ü Áõ°¡, ³»½Ã°æ ½Ã¼ú Áõ°¡, ȯÀÚ ¾ÈÀü¿¡ ´ëÇÑ °ü½É Áõ°¡, ÃÖ¼Ò Ä§½À ¼ö¼ú ¼±È£µµ Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

³ë·ÉÀα¸ Áõ°¡·Î ³»½Ã°æ Àçó¸® ½ÃÀå ¼ºÀå °ßÀÎÇÒ °ÍÀ¸·Î Àü¸Á

³ë·ÉÀα¸ÀÇ Áõ°¡´Â ³»½Ã°æ Àçó¸® »ê¾÷À» ¹ßÀü½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ³ëÀÎ Àα¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ³»½Ã°æ ½Ã¼ú°ú °°Àº ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡ÇÕ´Ï´Ù. ³ëÀΠȯÀÚµéÀº ³»½Ã°æ »ç¿ëÀ» Æ÷ÇÔÇÏ¿© º¸´Ù Á¤±âÀûÀÎ °ËÁø ¹× Áø´Ü ÀýÂ÷°¡ ´õ ÀÚÁÖ ÇÊ¿äÇÕ´Ï´Ù. ³»½Ã°æ Àç󸮴 ÀÌ·¯ÇÑ ½Ã¼úÀÇ ¾ÈÀü¼º°ú È¿°ú¸¦ º¸ÀåÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

¿¹¸¦ µé¾î, ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ 2022³â º¸°í¼­¿¡ µû¸£¸é, 2030³â±îÁö Áö±¸»óÀÇ Àα¸ 6¸í Áß 1¸íÀÌ 60¼¼ ÀÌ»ó °í·ÉÀÚ°¡ µÉ °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù. ÀÌ ±â°£ µ¿¾È 60¼¼ ÀÌ»ó ¼¼°è Àα¸ÀÇ ºñÀ²Àº 2020³â 10¾ï ¸í¿¡¼­ 14¾ï ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ¿¡ µû¶ó ³ëÀÎ Àα¸ÀÇ Áõ°¡´Â ³»½Ã°æ Àç󸮿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î À̾îÁ® ½ÃÀåÀ» ¹ßÀü½Ãų °ÍÀÔ´Ï´Ù.

ÃÖ¼Òħ½ÀÀû ¼ö¼ú¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡°¡ ³»½Ã°æ Àçó¸® ¼¼°è ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎ

ÃÖ¼Òħ½À ¼ö¼úÀº ÀüÅëÀûÀÎ ¼ö¼ú¹ýº¸´Ù Å« ÀåÁ¡ÀÌ Àֱ⠶§¹®¿¡ Á¡Á¡ ´õ Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÁ¡¿¡´Â ºÒÆíÇÔÀÌ Àû°í, ÀÔ¿ø ±â°£ÀÌ Âª°í, ¹®Á¦°¡ Àû°í, ÈäÅͰ¡ Àû°í, Á¶Á÷ ¼Õ»óÀÌ Àû´Ù´Â Á¡ µîÀÌ ÀÖ½À´Ï´Ù. ÃÖ¼Ò Ä§½À ¼ö¼úÀÇ Àαâ Áõ°¡´Â ȯÀÚ, ÀÇ·á ¼­ºñ½º Á¦°øÀÚ ¹× ¾÷°è Àüü¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ´Ù¾çÇÑ ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ³»½Ã°æ Àç󸮴 ÃÖ¼Ò Ä§½À ¼ö¼úÀ» °¡´ÉÇÏ°Ô ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ³»½Ã°æ ¼Òµ¶Àº ¼öµ¿ ¶Ç´Â ±â°è·Î ÇÒ ¼ö ÀÖ½À´Ï´Ù.

º¹°­°æ ÃÖ¼Ò Ä§½À ¼ö¼úÀÇ Áõ°¡´Â ½ÃÀåÀ» ÁÖµµÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, Ŭ¸®ºí·£µå Ŭ¸®´Ð(Cleveland Clinic)ÀÇ 2022³â º¸°í¼­¿¡ µû¸£¸é, ¸Å³â Àü ¼¼°èÀûÀ¸·Î 1,300¸¸ °ÇÀÇ º¹°­°æ ¼ö¼úÀÌ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ÀÌ ¼öÄ¡´Â ÇâÈÄ 5³â°£ 1% Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÃÖ¼Ò Ä§½À ¼ö¼úÀÇ Çʿ伺ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó È¿°úÀûÀÌ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ³»½Ã°æ Àçó¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿ä±¸µµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

À¯ÀÚ°Ý Àü¹®°¡ ºÎÁ·À¸·Î ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹·Î ÀÛ¿ë

³»½Ã°æ Àçó¸® Àåºñ¸¦ È¿°úÀûÀ¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Â ÀÚ°ÝÀ» °®Ãá Àü¹®°¡°¡ ºÎÁ·ÇÏ´Ù´Â °ÍÀº ÁÖ¿äÇÑ »ó¾÷Àû Á¦¾àÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀÇ ÀûÀýÇÑ ¸ð´ÏÅ͸µ ¹× À¯Áöº¸¼ö´Â ³»½Ã°æÀÇ ¼º°øÀûÀÎ ¼Òµ¶ ¹× ¸ê±ÕÀ» À§ÇØ ÇʼöÀûÀÔ´Ï´Ù. ±×·¯³ª ÀåºñÀÇ º¹À⼺°ú ÀÛµ¿¿¡ ÇÊ¿äÇÑ Àü¹® Áö½ÄÀ¸·Î ÀÎÇØ ÀÚ°ÝÀ» °®Ãá Àü¹®°¡¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÀÌ·¯ÇÑ ±â¼úÀÚ ºÎÁ·Àº ½Ã½ºÅÛ ¼º´É, ¾ÈÀü ±ÔÁ¤ Áؼö ¹× ȯÀÚ ¾ÈÀü º¸Àå Ãø¸é¿¡¼­ ¹®Á¦¸¦ ¾ß±âÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ºÎÁ·À» ÇØ°áÇÏ°í ±â¼úÀÚ¿¡°Ô ÀûÀýÇÑ ±³À°°ú ÀÚ¿øÀ» Á¦°øÇÏ´Â °ÍÀº ÀÌ·¯ÇÑ Á¦¾àÀ» ±Øº¹ÇÏ°í ³»½Ã°æ Àçó¸® »ç¾÷À» È®ÀåÇÏ´Â µ¥ Áß¿äÇÑ ¿ä¼ÒÀÔ´Ï´Ù.

COVID-19 ¿µÇ⠺м®

COVID-19ÀÇ À¯ÇàÀº ³»½Ã°æ Àçó¸® ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÃÆÀ¸¸ç, °¨¿° ¿¹¹æ ¹× °ü¸® ¹æ¹ý¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. °³Àκ¸È£±¸¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í °ø±Þ¸Á ¹®Á¦´Â Àçó¸® Àåºñ ¹× ¼Ò¸ðǰÀÇ °¡¿ë¼º°ú ºñ¿ë¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ³»½Ã°æ ½Ã¼ú°ú ȯÀÚ ¼öÀÇ º¯È­, ƯÈ÷ ºñÀÀ±Þ ¼ö¼úÀÇ ¿¬±â´Â Àçó¸® ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.

¿ø°Ý ÀÇ·á¿Í ¿ø°Ý ¸ð´ÏÅ͸µÀÇ »ç¿ëÀº »õ·Î¿î Àçó¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ÀÇ·á ½Ã¼³Àº û¼Ò °³¼±, Á÷¿ø ±³À° ¹× ¸ð´ÏÅ͸µ°ú °°Àº À§»ý ¹× Àçó¸® °üÇàÀ» ¿ì¼±½ÃÇϰí ÀÖ½À´Ï´Ù.

¿¹¸¦ µé¾î, 2021³â¿¡ ¹ßÇ¥µÈ ±¹¸³ ÀÇÇÐ µµ¼­°ü ³í¹®¿¡ µû¸£¸é ³»½Ã°æÀÇ ¾ÈÀüÇÑ Àç󸮸¦ º¸ÀåÇϱâ À§ÇØ Àå°©, °¡¿î, ¾È¸é º¸È£´ë ¹× ±âŸ Àåºñ¸¦ Æ÷ÇÔÇÑ Æ¯Á¤ ¿¹¹æ Á¶Ä¡°¡ ±ÇÀåµÈ´Ù°í ¹àÇû½À´Ï´Ù. ±×°ÍÀº ÁÖ·Î °¡±î¿î Àå·¡¿¡ »ê¾÷ÀÇ ¼ºÀåÀ» À§ÇØ ±×·¯ÇÑ Á¶Ä¡ÀÇ Çʿ伺À» °­Á¶ÇÕ´Ï´Ù. Àü¹ÝÀûÀ¸·Î COVID-19 Àü¿°º´Àº ³»½Ã°æ ÀýÂ÷¸¦ ÅëÇØ ȯÀÚÀÇ ¾ÈÀüÀ» º¸ÀåÇϱâ À§ÇØ ²÷ÀÓ¾ø´Â °æ°è¿Í ¼öÁ¤ÀÌ ÇÊ¿äÇÕ´Ï´Ù.

·¯½Ã¾Æ-¿ìÅ©¶óÀ̳ª ºÐÀïÀÇ ¿µÇ⠺м®

ÇöÀç ÁøÇà ÁßÀÎ ·¯½Ã¾Æ¿Í ¿ìÅ©¶óÀ̳ªÀÇ ºÐÀïÀº ³»½Ã°æ Àçó¸® ºÎ¹®¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ħ°ø°ú ±× °á°ú·Î ¹ß»ýÇÑ »ç°ÇÀº °ø±Þ¸Á¿¡ Àå¾Ö¸¦ ÀÏÀ¸ÄÑ ºÎǰ ºÎÁ·, ¹°·ù ¹®Á¦ ¹× ºñ¿ë Áõ°¡¸¦ ÃÊ·¡Çß½À´Ï´Ù.

ÀÌ·¯ÇÑ ¾î·Á¿òÀº ÀÎÇ÷¹ÀÌ¼Ç ¾Ð·Â°ú ÇÔ²² ÀÇ·á °í°´ÀÇ À繫 »óȲ¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÆÒµ¥¹Í(¼¼°èÀû ´ëÀ¯Çà)ÀÇ Áö¼ÓÀûÀÎ ¿µÇâÀ¸·Î ÀÇ·á ¼­ºñ½º(ƯÈ÷ ¼±ÅÃÀû ¼ö¼ú)ÀÇ È¸º¹ÀÌ ´Ê¾îÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ È¯°æ¿¡¼­ ÀÇ·á »ý»ê¼º Çâ»óÀÌ Á¡Á¡ ´õ Áß¿äÇØÁö°í ÀÖÀ¸¸ç, ³»½Ã°æ Àçó¸® ºÐ¾ßÀÇ ½º¸¶Æ®ÇÑ Á¦Ç°°ú ¼­ºñ½º´Â ÀÌ·¯ÇÑ ¼ö¿ä¸¦ ÃæÁ·½ÃŰ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå Á¤ÀÇ¿Í °³¿ä

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ¿ªÇÐ

Á¦5Àå »ê¾÷ ºÐ¼®

Á¦6Àå COVID-19 ºÐ¼®

Á¦7Àå Á¦Ç°º°

Á¦8Àå ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå Áö¿ªº°

Á¦10Àå °æÀï »óȲ

Á¦11Àå ±â¾÷ °³¿ä

Á¦12Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Market Overview

The Global Endoscope Reprocessing Market reached US$ 2.3 billion in 2022 and is expected to reach US$ 4.5 billion by 2030 growing with a CAGR of 9.2% during the forecast period 2023-2030). The growing awareness of healthcare, advancement in technologies such as integration of connectivity features, data tracking, and remote monitoring capabilities are driving up demand for endoscope reprocessing market trends.

Endoscope reprocessing is critical in infection prevention methods and for ensuring patient safety during medical operations. Endoscope reprocessing is critical for guaranteeing effective contamination removal and lowering the risk of healthcare-associated illnesses. Ultrasonic washers, sterilizers, washer disinfectors, drying and storage cabinets, endoscope tracking systems, and other solutions are included in the market.

The global endoscope reprocessing market scope comprises components encompassing product types, high-level disinfectants and test strip, detergents and wipes, automated endoscope reprocessors, endoscope drying, storage, and transport systems which has increased usage of endoscope reprocessing market share.

The global market for endoscope reprocessing is expanding as a result of factors including rising prevalence of healthcare-associated infections (HAI's), increasing number of endoscopic procedures, increasing focus on patient safety, increasing preference for minimally invasive surgeries, and growing geriatric population.

Market Dynamics

Rising Geriatric Population is Estimated to Drive the Growth of the Endoscope Reprocessing Market

The growing geriatric population is projected to propel the endoscope reprocessing industry forwards. As the older population grows, so does the demand for healthcare services such as endoscopic procedures. Geriatric patients frequently require more regular medical examinations and diagnostic procedures including the use of endoscopes. Endoscope reprocessing is critical to ensuring the safety and effectiveness of these procedures.

For instance, according to World Health Organization (WHO) 2022 report, by 2030, about one out of every six people on the planet will be 60 or older. Within this time span, the share of the world population aged 60 and up is expected to increase from 1 billion in 2020 to 1.4 billion. As a result, the growing elderly population adds to an increased demand for endoscope reprocessing, propelling the market forwards.

Rising Preference toward Minimal Invasive Procedures is the Major Driver in the Global Endoscope Reprocessing Market

Minimally invasive operations are becoming increasingly popular due to their significant advantages over traditional surgical techniques. These advantages include less discomfort, shorter hospital stays, fewer problems, less scarring, and less tissue damage. The growing popularity of minimally invasive surgeries is being driven by a variety of factors affecting patients, healthcare providers, and the industry as a whole. Endoscopic reprocessing is critical in enabling minimally invasive operations. Endoscope disinfection can be done manually or using machines.

The rising laproscopic minimal invasive surgeries is major factor to drive the market. For instance, according to Cleveland Clinic organization 2022 article, every year, 13 million laparoscopic surgeries are performed worldwide. These figures are expected to rise by 1% during the following five years. As the need for minimally invasive surgeries grows, consequently rises the requirement for effective and dependable endoscopic reprocessing solutions.

Lack of Qualified Professional will Hamper the Growth of the Market

The lack of qualified professionals to effectively monitor endoscopic reprocessing equipment is a key commercial limitation. The appropriate monitoring and maintenance of these systems are critical to ensuring successful disinfection and sterilization of endoscopes. However, the complexity of the equipment and the specialized expertise necessary for its operation creates a demand for qualified specialists.

The shortage of such technicians causes issues in terms of system performance, compliance with safety regulations, and guaranteeing patient safety. Addressing this shortfall, as well as providing proper training and resources for technicians, are critical components in overcoming this constraint and supporting the expansion of the endoscopic reprocessing business.

COVID-19 Impact Analysis

The COVID-19 pandemic had a major effect on the endoscope reprocessing market, with a greater emphasis on infection prevention and control methods. Increased demand for personal protection equipment, as well as supply chain problems, have impacted the availability and cost of reprocessing equipment and supplies. Endoscopy procedures and patient volume change, especially the deferral of non-urgent operations, have influenced the demand for reprocessing services.

The use of telemedicine and remote monitoring has increased the demand for novel reprocessing solutions. Healthcare facilities have prioritized hygiene and reprocessing practices, such as improved cleaning, employee training, and monitoring.

For instance, according to National Library of Medicine article published in 2021, stated that to ensure the safe reprocessing of endoscopes, certain precautions, which include gloves, gowns, face shields, and other equipment, are advised. That mainly, emphasizes the need for such measures for the industry's growth in the near future. Overall, the COVID-19 pandemic has required constant vigilance and modification to guarantee patient safety throughout endoscopic procedures.

Russia-Ukraine War Impact Analysis

The ongoing conflict between Russia and Ukraine has had a considerable impact on the endoscope reprocessing sector. The invasion and resulting events have produced hurdles in the supply chain, resulting in component shortages, logistical challenges, and increased costs.

These difficulties, combined with inflationary pressures, have impacted the financial status of healthcare clients. Furthermore, the pandemic's continued impacts have slowed the recovery of healthcare services, notably elective surgeries. Improving healthcare productivity has become increasingly crucial in this environment, and smart products and services in the field of endoscope reprocessing can help to meet this demand.

Segment Analysis

The global endoscope reprocessing market is segmented based on product, end user and region.

Hospitals Segment Accounts for 41.1% of Market Share Owing to the Usage of Endoscopic Devices

Hospitals are important consumers of endoscopes, using them in a variety of diagnostic and therapeutic procedures such as gastrointestinal, urological, and pulmonary interventions. Because of the high volume of surgical procedures performed in hospitals, there is an elevated danger of cross-contamination and the spread of infections. To overcome this issue, hospitals are widely implementing sterilizers, automated endoscope reprocessors, and other advances in technology.

For instance, in April 2023, Children's Hospital Los Angeles (CHLA) became the first healthcare centre in California to use the EvoEndo Single-Use Endoscopy System for diagnostic unsedated TNE procedures of the Upper Gastrointestinal (GI) Tract. So to assure the safety and effectiveness of endoscopic treatments, they prioritize the use of efficient and dependable reprocessing methods. Endoscope cleaning, disinfection, and sterilization are handled by dedicated reprocessing departments or facilities equipped with specialized equipment and well-trained people.

Furthermore, hospitals exhibit a commitment to preventing cross-contamination and infections by striving to maintain strict reprocessing procedures and standards. The hospital segment's dominance in the endoscope reprocessing market can be ascribed to the large volume of endoscopic procedures conducted in hospitals, as well as their continuous commitment to patient safety and infection control. Thus, owing to the above factors the segment is expected to grow over the forecast period.

Geographical Analysis

North America Accounted for Approximately 39.3% of the Market Share Owing to the Increasing Collaborations

North America is likely to maintain its dominant position in the market due to increased investments and collaborations. The region's hostile commitment to encouraging breakthroughs and developments in endoscope reprocessing technology has garnered considerable investments from industrial players and academic organizations. Collaborations between healthcare providers, manufacturers, and regulatory authorities have also contributed to the market's rise.

For instance, in January 2023, AA Medical, a company dedicated to providing sustainable solutions for the new and resale medical device equipment sectors, announced a successful collaboration with Certified Endoscopy Products, a well-known medical device reprocessing company situated in Chicago. This collaboration seeks to gain a dominant market position by delivering high-quality reprocessing services for endoscopic equipment, as well as catering to the orthopedic and other surgical device sectors. Thus owing to the above factors the region is expected to dominate the market over the forecast period.

Competitive Landscape

The major global players in the endoscope reprocessing market include: Cantel Medical, Ecolab Inc, STERIS plc., Olympus Corporation, Getinge AB, Belimed AG , CONMED Corporation, Laboratoires Anios, SciCan Inc., HOYA Corporation, among others.

Why Purchase the Report?

The global endoscope reprocessing market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

Table of Contents

1. Methodology and Scope

2. Definition and Overview

3. Executive Summary

4. Dynamics

5. Industry Analysis

6. COVID-19 Analysis

7. By Product

8. By End User

9. By Region

10. Competitive Landscape

11. Company Profiles

LIST NOT EXHAUSTIVE

12. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â